🇺🇸 FDA
Patent

US 8563034

Dual release oral tablet compositions of dexlansoprazole

granted A61KA61K31/4439A61K9/2009

Quick answer

US patent 8563034 (Dual release oral tablet compositions of dexlansoprazole) held by SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4439, A61K9/2009, A61K9/2013, A61K9/2886